Cargando…

Interleukin-6 signaling in podocyte hypertrophy

Detalles Bibliográficos
Autor principal:	Cha, Dae Ryong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142302/ https://www.ncbi.nlm.nih.gov/pubmed/27957412 http://dx.doi.org/10.1016/j.krcp.2016.10.001

Ejemplares similares

The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy
por: Jo, Hyung Ah, et al.
Publicado: (2016)

The classic signalling and trans‐signalling of interleukin‐6 are both injurious in podocyte under high glucose exposure
por: Lei, Chun‐Tao, et al.
Publicado: (2017)

Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes
por: Manda, Gina, et al.
Publicado: (2015)

Where do we stand on human diabetic nephropathy?
por: Ryong Cha, Dae
Publicado: (2013)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Diabetic kidney disease, revisited: where do we stand?
por: Cha, Dae Ryong
Publicado: (2022)

Fetuin‐A aggravates lipotoxicity in podocytes via interleukin‐1 signaling
por: Orellana, Jana M., et al.
Publicado: (2017)

Corrigendum to “Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes”
por: Manda, Gina, et al.
Publicado: (2018)

Effects of high glucose on interleukin-6 production in human mesangial cells.
por: Ihm, Chun-Gyoo, et al.
Publicado: (2002)

Angiopoietins Modulate Endothelial Adaptation, Glomerular and Podocyte Hypertrophy after Uninephrectomy
por: Chiang, Wen Chih, et al.
Publicado: (2013)

Nutrition for Podocyte Repair in Nephrotic Syndrome?
por: Aquilani, Roberto, et al.
Publicado: (2023)

MicroRNAs for podocyte injury in diabetic nephropathy
por: Morishita, Yoshiyuki
Publicado: (2021)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy
por: Hsu, Yu-Hsiang, et al.
Publicado: (2017)

The ubiquitous interleukin-6: a time for reappraisal
por: Fisman, Enrique Z, et al.
Publicado: (2010)

Interleukin-6: a local pain trigger?
por: Svensson, Camilla I
Publicado: (2010)

How are podocytes affected in nail–patella syndrome?
por: Witzgall, Ralph
Publicado: (2008)

Podocytes and microRNA-30/Cx43 axis in diabetic nephropathy
por: Kim, Seo Rin, et al.
Publicado: (2021)

Elevated interleukin‐6, interleukin‐10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
por: Godkin, Andrew, et al.
Publicado: (2020)

Measurement of Interleukin-6 Levels in COVID: Illuminative or Illogical?
por: Hegde, Ashit
Publicado: (2022)

Physical activity, interleukin-6 change, and gait speed
por: Panza, Francesco, et al.
Publicado: (2023)

Podocyte Sphingolipid Signaling in Nephrotic Syndrome
por: Li, Guangbi, et al.
Publicado: (2021)

Effects of Interleukin-13 and Montelukast on the Expression of Zonula Occludens-1 in Human Podocytes
por: Park, Se Jin, et al.
Publicado: (2015)

Hypertrophy of the Maxilla
Publicado: (1872)

Ligation of α-Dystroglycan on Podocytes Induces Intracellular Signaling: A New Mechanism for Podocyte Effacement?
por: Vogtländer, Nils P. J., et al.
Publicado: (2009)

Pretenders and Contenders: Inflammation, C‐Reactive Protein, and Interleukin‐6
por: Daniels, Lori B.
Publicado: (2017)

Treatment of severe covid-19 with interleukin 6 receptor inhibition
por: Rajasundaram, Skanda, et al.
Publicado: (2022)

C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation
por: Lee, Jiyoun, et al.
Publicado: (2017)

Podocyte Foot Process Effacement Precedes Albuminuria and Glomerular Hypertrophy in CD2-Associated Protein Deficient Mice
por: Basgen, John M., et al.
Publicado: (2021)

Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling
por: Liu, Min, et al.
Publicado: (2017)

Molecular dissection of cardiac hypertrophy induced by interleukin-18
por: Majumdar, Sirshendu, et al.
Publicado: (2009)

VCP represses pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2017)

Podocytes
por: Reiser, Jochen, et al.
Publicado: (2016)

Tyrosine Kinase Signaling in Kidney Glomerular Podocytes
por: Hattori, Seisuke, et al.
Publicado: (2011)

Modulation of proteomic and inflammatory signals by Bradykinin in podocytes
por: Saoud, Richard, et al.
Publicado: (2020)

Nitric-Oxide-Mediated Signaling in Podocyte Pathophysiology
por: Semenikhina, Marharyta, et al.
Publicado: (2022)

RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal
por: Huang, Zongshun, et al.
Publicado: (2016)

Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2020)

Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup
por: Rubin, Eric J., et al.
Publicado: (2021)

OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition
por: Lantieri, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_adko88k6iqlu2430ive9aeragp